Scentian Bio Closes $2.1M Seed Funding

Scentian Bio

Scentian Bio, an Aukland, New Zealand-based biosensor platform provider, raised $2.1M in Seed funding.

The round, which brought the total amount to $4.4M, was led by Finistere Ventures and Toyota Ventures, with participation from Icehouse Ventures and Our Crowd, among others. Scentian Bio also announced the addition of Finistere Ventures’ Dean Tilyard to its Board of Directors.

The company intends to use the funds to grow its team, further the development of its technology platform, and accelerate commercialization plans for its industry-specific solution offerings – starting with the food industry and then moving into the medical sector and beyond.

Led by Jonathan Good, CEO, Scentian Bio combines insect olfactory receptors with nanotechnology and artificial intelligence to deliver ultra-sensitive taste and smell solutions for the food and health industries. Spun out from New Zealand’s Plant & Food Research, its biosensor platform leverages patented technology based on decades of scientific research to make the real-time, portable interpretation of complex chemical signatures possible.

Its first digital biosensor solution, expected to launch commercially at the end of 2024, will provide fast quality control of the smell and taste attributes for key food ingredients. Initially focusing on essential oils, Scentian Bio plans to expand its quality control solutions to include other key ingredients over time.